Astrana Health Valuation

AMEHDelisted Stock  USD 34.07  0.34  0.99%   
At this time, the firm appears to be overvalued. Astrana Health shows a prevailing Real Value of $28.43 per share. The current price of the firm is $34.07. Our model approximates the value of Astrana Health from analyzing the firm fundamentals such as Profit Margin of 0.03 %, return on equity of 0.0976, and Current Valuation of 1.81 B as well as examining its technical indicators and probability of bankruptcy.
Please note that Astrana Health's price fluctuation is very steady at this time. Calculation of the real value of Astrana Health is based on 3 months time horizon. Increasing Astrana Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Astrana Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Astrana Stock. However, Astrana Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  34.07 Real  28.43 Hype  34.07
The intrinsic value of Astrana Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Astrana Health's stock price.
Real Value
Estimating the potential upside or downside of Astrana Health helps investors to forecast how Astrana stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Astrana Health more accurately as focusing exclusively on Astrana Health's fundamentals will not take into account other important factors:

Astrana Health Total Value Analysis

Astrana Health is presently forecasted to have valuation of 1.81 B with market capitalization of 1.86 B, debt of 229.36 M, and cash on hands of 273.71 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Astrana Health fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.81 B1.86 B229.36 M273.71 M

Astrana Health Investor Information

About 26.0% of the company shares are held by company insiders. The book value of Astrana Health was presently reported as 12.74. The company had not issued any dividends in recent years. Astrana Health had 1:10 split on the 27th of April 2015. Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company was founded in 1994 and is headquartered in Alhambra, California. Apollo Medical operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 1133 people. For more info on Astrana Health please contact MPH MD at 626 282 0288 or go to

Astrana Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Astrana Health has an asset utilization ratio of 137.43 percent. This signifies that the Company is making $1.37 for each dollar of assets. An increasing asset utilization means that Astrana Health is more efficient with each dollar of assets it utilizes for everyday operations.

Astrana Health Ownership Allocation

Astrana Health holds a total of 45.45 Million outstanding shares. Astrana Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that on January 21, 2024, Representative Judy Chu of US Congress acquired $100k to $250k worth of Astrana Health's common stock.

Astrana Health Profitability Analysis

The company reported the previous year's revenue of 1.33 B. Net Income was 48.51 M with profit before overhead, payroll, taxes, and interest of 199.48 M.

About Astrana Health Valuation

The delisted stock valuation mechanism determines the current worth of Astrana Health on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Astrana Health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Astrana Health based exclusively on its fundamental and basic technical indicators. By analyzing Astrana Health's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Astrana Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Astrana Health. We calculate exposure to Astrana Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Astrana Health's related companies.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company was founded in 1994 and is headquartered in Alhambra, California. Apollo Medical operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 1133 people.

8 Steps to conduct Astrana Health's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Astrana Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Astrana Health's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Astrana Health's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Astrana Health's revenue streams: Identify Astrana Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Astrana Health's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Astrana Health's growth potential: Evaluate Astrana Health's management, business model, and growth potential.
  • Determine Astrana Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Astrana Health's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Astrana Health Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding45.6 M
Quarterly Earnings Growth Y O Y-0.06
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Astrana Stock

If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data